what is going on with tirzepatide Mechanism of Weight Loss & Blood Sugar Control Tirzepatide Side Effects You Should

VikingVK2735 On Feb 27, 2024, Viking announced its GLP-1/GIP receptor agonist VK2735 met primary and secondary endpoints in the Phase II obesity trial

For a low-calorie, high-protein noodle option, the Konjac Chicken Chow Mein fits into a GLP-1 supportive plan

J Biomed Sci 31 , 102 (2024)

RELATED QUESTIONS What are the current treatment options for Parkinson's disease

Screening involved initial assessment of titles and abstracts for relevance, followed by a thorough examination of full texts based on predetermined inclusion and exclusion criteria

To serve as mucoadhesive polymers, the polymers should possess some general physiochemical features such as predominantly anionic hydrophilicity with numerous hydrogen bond forming groups, suitable surface property for wetting mucus/mucosal tissue surfaces and sufficient flexibility to penetrate the mucus network